Luigi Costa
Chief Executive Officer
Pharmaceutical technology
Nordic Nanovector ASA
New Zealand
Biography
Mr. Luigi Costa has served as Chief Executive Officer of Nordic Nanovector ASA since September 1, 2014. He has more than 20 years of experience in the international pharmaceuticals and biotech industry. Previously, he held the position of vice president of Europe, Middle East and Africa for Onyx Pharmaceuticals, a global biopharmaceutical company based in San Francisco, California. Mr. Costa was responsible for the startup of the company’s international organization and for the prelaunch and launch of its hematology drug, Kyprolis, in over fifty countries outside the USA. Prior to joining Onyc Pharmaceuticals, he spent eight years with Amgen holding leading management positions including head of International Oncology Franchise and general manager of Italy and France. He has also held various positions with Eli Lilly. He holds a Bachelor of Science in Business Administration from the University of Parma and an MBA from SDA Bocconi in Milan.
Research Interest
Nanomedicine Design of Nanodrugs Personalized Nanomedicine Nanomaterials for drug delivery
